TIGATUZUMAB

UNII: 237GB6IDKO
Preferred Substance Name: TIGATUZUMAB

918127-53-4
ANTI-DR5 MOAB
ANTI-TRAIL-R2 MOAB
CS-1008
IMMUNOGLOBULIN G1, ANTI-(HUMAN CYTOKINE RECEPTOR DR5 (DEATH RECEPTOR 5)) (HUMAN-MOUSE MONOCLONAL TRA-8 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL TRA-8 .KAPPA.-CHAIN, DIMER
TIGATUZUMAB [INN]
TIGATUZUMAB [WHO-DD]
TRA-8

Common Chemistry
i
Inxight Drugs
i
NCATS GSRS Full Record
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

About, Contact Us, Copyright, Privacy, Accessibility

U.S. Food and Drug Administration, 10903 New Hampshire Ave, Silver Spring, MD 20993-0002

U.S. Food and Drug Administration, Health & Human Services

Freedom of Information Act

TIGATUZUMAB

Synonyms and Mappings

Resources

Note